KHRN.H — Khiron Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual cashflow statement for Khiron Life Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2017 May 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.045 | -19.8 | -36.4 | -23.9 | -33.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | 3.29 | 8.52 | 0.189 | 13.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.023 | 1.33 | -3.18 | -1.94 | -1.86 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.021 | -14.8 | -30.1 | -24.5 | -20.4 |
| Capital Expenditures | — | -3.83 | -6.09 | -2.69 | -1.74 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -5.39 | -25.9 | 27.6 | -0.342 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -9.22 | -32 | 24.9 | -2.09 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.005 | 37.6 | 57 | 12.2 | 10.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.016 | 13.2 | -5.67 | 12.3 | -12.7 |